ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

NCI To Fund Approximately 850 Competing Grants In Fiscal 1986 Under Latest Budget Projections

February 28, 1986

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

Program Announcement In Preventative Oncology

May 21, 1982